NBIX

Neurocrine Biosciences, Inc. News Headlines

$39.05
*  
1
2.5%
Get NBIX Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading NBIX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    NBIX After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Neurocrine Biosciences: A More Solid Investment After Recent Secondary
2/21/2015 11:12:00 AM - Seeking Alpha


Neurocrine Biosciences Prices Public Offering Of 6.94 Mln Shares At $36/shr
2/19/2015 7:11:00 AM - RTT News


Neurocrine Bio. To Present At Leerink Global Conference; Webcast At 8:50 AM ET
2/11/2015 7:51:00 AM - RTT News


Neurocrine Biosciences Posts Wider Q4 Loss
2/9/2015 4:30:00 PM - RTT News


Neurocrine Biosciences Q4 14 Earnings Conference Call At 5:00 PM ET
2/9/2015 3:00:00 PM - RTT News


Neurocrine Bio. To Present At J.P. Morgan Conference; Webcast At 11:00 AM ET
1/15/2015 10:00:00 AM - RTT News


Seeking Alpha's Biotech Weekly: Gilead Rises With Phenex, Bass's Patent Attack, And More
1/9/2015 4:00:00 PM - Seeking Alpha


Neurocrine Biosciences Starts A Data-Rich Year On The Right Foot
1/9/2015 11:37:00 AM - Seeking Alpha


FOLD Unfolds, No Pain, All Gain For NBIX, VSAR Picks Up Velocity, RVNC On Watch
1/9/2015 1:16:00 AM - RTT News


Neurocrine Biosciences Inc. (NBIX) Has Surged To A New High On Phase 3 News
1/8/2015 9:38:00 AM - RTT News


AbbVie: Phase 3 Elagolix Study Shows Positive Top-Line Results
1/8/2015 8:18:00 AM - RTT News


Our 3 Best Performing Stocks Of 2014
1/5/2015 6:52:00 PM - Seeking Alpha


15 Biotech Names For 2015
1/5/2015 2:37:00 PM - Seeking Alpha


Neurocrine Bio. To Present At Oppenheimer Conference; Webcast At 10:55 AM ET
12/10/2014 9:55:00 AM - RTT News


Neurocrine Biosciences Looking Forward To A Big Year
11/6/2014 11:57:00 AM - Seeking Alpha


End Of The Year Events To Drive Some Of October's Beaten Up Biotech Companies
10/20/2014 7:40:00 AM - Seeking Alpha


KVB Capital LLC's Best And Worst Third-Quarter Performers
10/10/2014 2:42:00 PM - Seeking Alpha


Neurocrine Biosciences Moving Ahead With '854
8/9/2014 7:48:00 AM - Seeking Alpha


2 Biotechs Race To Treat Movement Disorders
6/27/2014 8:00:00 AM - Seeking Alpha


Neurocrine In "Hurry Up And Wait" Mode
6/11/2014 5:18:00 PM - Seeking Alpha


Fundamentals Continue To Look Strong At Neurocrine Bio
2/8/2014 9:47:00 AM - Seeking Alpha


Kinect-2 Puts '854 Back Into Play For Neurocrine
1/8/2014 9:50:00 AM - Seeking Alpha


Increasing Price Target On Neurocrine Bio After Phase 2 Success
1/8/2014 9:34:00 AM - Seeking Alpha


Look For These Biotech Stocks To Move In 2014
12/19/2013 11:14:00 AM - Seeking Alpha


Neurocrine Will Get Second Chance To Offer Up VMAT-2 Data In December
10/30/2013 3:42:00 PM - Seeking Alpha